||Dr. Samuel Nussbaum is executive vice president, Clinical Health Policy, and chief medical officer for WellPoint, Inc. He is the key spokesperson and policy advocate for WellPoint. In addition, he oversees corporate medical and pharmacy policy to ensure the provision of clinically proven, effective care. Dr. Nussbaum collaborates with key leaders in the industry – physicians, hospitals and national policy and health care organizations – to shape an agenda for quality, safety and clinical outcomes and to improve patient care for WellPoint’s 34 million medical members nationwide. In addition, Dr. Nussbaum partners with WellPoint’s Consumer Business Unit to advance WellPoint’s international business and with HealthyCare Solutions, the strategic area focused on improving our customers’ access to innovative health care services. |
Dr. Nussbaum currently serves on the Boards of the National Quality Forum (NQF), the OASIS Institute, and BioCrossroads, an Indiana-based public-private collaboration that advances and invests in the life sciences. Dr. Nussbaum is a Professor of Clinical Medicine at Washington University School of Medicine and serves as adjunct professor at the Olin School of Business, Washington University.
Dr. Nussbaum has served as president of the Disease Management Association of America, chairman of the National Committee for Quality Health Care, as chair of America's Health Insurance Plans (AHIP) Chief Medical Officer Leadership Council, as a member of the AHIP Board, and on the Secretary of Health and Human Services Advisory Committee on Genetics, Health, and Society. Dr. Nussbaum received the 2004 Physician Executive Award of Excellence from the American College of Physician Executives and Modern Physician magazine.
Prior to joining WellPoint, Dr. Nussbaum served as executive vice president, Medical Affairs and System Integration, of BJC Health Care, where he led integrated clinical services across the health system and served as president of its medical group. He earned his medical degree from Mount Sinai School of Medicine. He trained in internal medicine at Stanford University Medical Center and Massachusetts General Hospital and in endocrinology and metabolism at Harvard Medical School and Massachusetts General Hospital, where he directed the Endocrine Clinical Group. As a professor at Harvard Medical School, Dr. Nussbaum’s research led to new therapies to treat skeletal disorders and new technologies to measure hormones in blood.